Reporting owner · Q3 2026 · CIK 1811946

Westlake BioPartners Opportunity Fund I, L.P.: insider trades.

Westlake BioPartners Opportunity Fund I, L.P. reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.

Transactions
7
Purchases (P)
0
Sales (S)
0
Companies
1
Name as filed
Westlake BioPartners Opportunity Fund I, L.P.

Companies

CompanyRelationshipTransactions
Latigo Biotherapeutics, Inc. (LTGO)TenPercentOwner7

Transactions

7 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-10Latigo Biotherapeutics, Inc.C938,979—1,368,532Form 4
2026-08-10Latigo Biotherapeutics, Inc.C3,547,842—4,916,374Form 4
2026-08-10Latigo Biotherapeutics, Inc.C2,066,857—2,094,813Form 4
2026-08-10Latigo Biotherapeutics, Inc.C165,519—5,160,847Form 4
2026-08-10Latigo Biotherapeutics, Inc.C1,027,635—5,944,009Form 4
2026-08-10Latigo Biotherapeutics, Inc.C3,464,072—3,510,927Form 4
2026-08-10Latigo Biotherapeutics, Inc.C1,484,401—4,995,328Form 4

Questions

What stock did Westlake BioPartners Opportunity Fund I, L.P. buy or sell?

Westlake BioPartners Opportunity Fund I, L.P. reported 7 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.

Is Westlake BioPartners Opportunity Fund I, L.P. the same person as other filers with this name?

This page covers SEC CIK 1811946 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/westlake-biopartners-opportunity-fund-i-l-p-1811946.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.